Cosmo Pharmaceuticals N.V.

CMOPF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$50,749$44,296$54,556$50,275
Short-Term Investments$1,182$98,667$78,858$0
Receivables$21,616$18,941$23,649$28,454
Inventory$12,379$13,510$13,902$14,198
Other Curr. Assets$26,606$26,844$12,629$9,299
Total Curr. Assets$187,226$202,258$183,594$102,226
Property Plant & Equip (Net)$29,774$29,088$27,372$28,588
Goodwill$24,005$24,005$24,005$24,005
Intangibles$329,126$331,925$374,461$368,993
Long-Term Investments$11,247-$66,827$3,169$3,286
Tax Assets$0$18,716$0$17,130
Other NC Assets$28,952$107,607$25,651$9,752
Total NC Assets$423,104$444,514$454,658$451,754
Other Assets$0$0$0$0
Total Assets$610,330$646,772$638,252$553,980
Liabilities
Payables$11,027$9,100$14,675$8,783
Short-Term Debt$756$817$741$897
Tax Payable$0$20,611$12,073$2,681
Deferred Revenue$0$0$16,840$9,303
Other Curr. Liab.$36,936$17,740-$6,451$4,050
Total Curr. Liab.$48,719$48,268$37,878$25,714
LT Debt$1,943$1,384$714$942
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$90,811$0$92,610
Other NC Liab.$92,692$1,218$94,274$3,755
Total NC Liab.$94,635$93,413$94,988$97,307
Other Liabilities$0$0$0$0
Cap. Leases$2,276$1,780$896$1,280
Total Liabilities$143,354$141,681$132,866$124,944
Equity
Pref Stock$0$0$0$65,329
Common Stock$4,562$4,562$4,562$4,562
Retained Earnings$363,348$323,064$373,527$232,673
AOCI-$42,443$0-$21,388-$22,662
Other Equity$134,772$170,704$141,742$142,258
Total Equity$460,239$498,330$498,443$422,160
Supplemental Information
Minority Interest$6,737$6,761$6,943$6,876
Total Liab. & Tot. Equity$610,330$646,772$638,252$553,980
Net Debt-$48,050-$42,095-$53,101-$48,436